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Mechanisms of the Biological Effects of
PCBs, Polychiorinated Dibenzo-dioxins
and Polychiorinated Dibenzofurans in
Experimental Animals
by Robert A. Neal*
Polychlorinated biphenyls, certain polychlorinated dibenzo-p-dioxins and certain polychlorinated di-
benzofurans cause avariety ofbiological effects in experimental animals. The mechanism ofthe induction
of certain enzymes is perhaps best understood. That is, there is binding of certain chlorinated biphenyls,
dibenzo-p-dioxins and dibenzofurans to a receptor, translocation ofthe compound-receptor complex into
the nucleus followed by an increased activity of a number of enzymes in the cell.
Although the concentration of this receptor in various tissues of some mouse strains correlates well
with the intensity of some of the biological effects observed in the mouse strains exposed to these com-
pounds, this correlation apparently does not extend across various species. The current evidence suggests
that the acute toxic effects of TCDD in various species is in some way associated with binding of TCDD
to the receptor. However, biological effects of TCDD in addition to those resulting from binding to the
receptor may be required to produce acute toxicity and, perhaps, other effects.
The acute toxic effects ofTCDD are probably caused by the parent compound rather than metabolites;
however, thisconclusion mustbeviewed astentative. Also, itcannotbeexcluded atthistimethatbiological
effects other than acute toxicity may be caused by metabolites of TCDD. Finally, the acute toxic effects
ofTCDD appear not to be related, at least not directly, to the rate ofmetabolism ofTCDD in experimental
animals nor to the half-life of excretion.
Polychlorinated biphenyls (PCBs) and polybromi-
nated biphenyls (PBBs) have enjoyed widespread use
in commerce. The most important uses are as plasticiz-
ers, transformer fluids, hydraulic fluids and flame re-
tardants. Polychlorinated dibenzofurans occasionally
occur as contaminants of samples of PCBs. The chlor-
inated dibenzo-p-dioxins are formed as by-products in
the synthesis of polychlorinated phenols. The polyhal-
ogenated dibenzofurans and dibenzo-p-dioxins also oc-
cur as products of combustion (1,2).
Commercial PCBs and PBBs produce a wide variety
ofbiological effects in experimental animals. The most
important of these include enzyme induction and inhi-
bition(3), decreasedreproductive efficiency (4), changes
in liver morphology (5), changes in plasma lipid concen-
trations (6), hepatic porphyria (7) decreased immuno-
competence (8), dermatological effects (9) and production
of tumors in the livers of rodents (10).
Although a great deal is known about the dose-re-
sponserelationship ofcommercial PCBsregardingtheir
various biological effects in experimental animals, the
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biological mechanism ofthese effects is less well under-
stood. It is apparent that a portion of the induction of
certain enzymes by a few of the individual isomers of
the PCBs is because ofthe affinity ofthese isomers for
a receptor protein in the cytosol of mammalian cells
which controls the activity of enzymes associated with
the regulator gene referred to as the Ah locus (11).
However, the majority of the PCB isomers present in
commercial mixtures have no affinity for this receptor
protein although they have the capacity to increase the
activity of certain enzymes in mammalian cells. Thus,
the biological mechanism ofthe majority ofthe enzyme
induction produced by commercial PCBs is not under-
stood at present.
ThereisevidencethatPCBsmaybecausingincreases
in rodent liver tumors largely by mechanisms which do
not involve permanent changes in the phenotypic
expression ofhepatocytes (12-14). In otherwords, they
may be acting as promoters.
The mechanism by which PCBs cause hepatic por-
phyria is the best understood ofallthe biological effects
ofthis mixture ofcompounds. The biological event lead-
ing to the hepatic porphyria appears to be the inhibition
ofuroporphyrinogen decarboxylase, the enzyme that isR. A. NEAL
responsible for the stepwise decarboxylation ofuropor-
phyrinogen to coproporphyrinogen (15). The inhibition
ofthis enzyme leads to the increased accumulation and
excretion ofporphyrins containinganumberofcarboxyl
groups. Interestingly, Elder and Sheppard (16) have
recentlyshownthatthedecreaseinthecatalyticactivity
of the uroporphyrinogen decarboxylase activity seen
with the porphyrogenic agent hexachlorobenzene is ac-
complished without a decrease in the amount of im-
munoreactive enzyme protein.
Certain isomers of the polychlorinated dibenzo-p-
dioxins and polychlorinated dibenzofurans produce a
number of biological effects in experimental animals.
The most prominent ofthese are enzyme induction, le-
thality, a wasting syndrome, lymphoid involution, he-
patic damage (in some but not all species), chloracne (in
a limited number ofspecies), hepatic porphyria, gastric
lesionsandurinarytracthyperplasia(againonlyinsome
species), edema (in certain select species), hyperlipi-
demia, reproductive toxicity, teratogenic effects and the
induction of an increase in tumor incidences in various
organs ofrats and mice (17). The concentrations ofthe
select chlorinated dibenzo-p-dioxins and dibenzofurans
that cause these biological effects are almost always
many orders of magnitude lower than the concentra-
tions of commercial PCBs required to cause the same
or similar biological effects.
The remainder of the discussion will be largely con-
fined to the mechanisms of toxicity of the polychlori-
nated dibenzo-p-dioxins and more specifically to the
specific isomer 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). There are 75 possible isomers of the chlori-
nated dibenzo-p-dioxins. The isomer most biologically
active in experimental animals appears to be TCDD.
The single dose of TCDD which produces acute le-
thalityin anumberofanimalspeciesvariesquitewidely
(Table 1). Of the animal species so far examined, the
guinea pig (2 ,ug/kg) (18) and the hamster (>3000 ,ug/
kg) (19,20) occupy the extremes. The LD50 for TCDD
to the remainder of the animals that have been exam-
ined isbetweenthese two extremes. The LD50ofTCDD
Table 1. Single dose LD50 values for TCDD.
Species
Guinea pig
Monkey
Rat
Adult male
Weanling male
3-MC pretreated
weanling male
Adult female
Rabbit
Rabbit
Mouse
C57BL/6J
DBA/2J
B6D2F1/J
Hamster
Hamster
Route
Oral
Oral
IP
IP
IP
IP
Oral
Skin
IP
IP
IP
IP
Oral
LD5o,
jig/kg
2
50
Reference
(18)
(18)
60 (21)
25 (21)
44 (21)
25 (21)
115 (23)
275 (23)
132
620
300
> 3000
5051
(22)
(22)
(22)
(19)
(20)
Table 2. Enzymes induced by TCDD in experimental animals.
Cytochrome P-450
UDP-glucuronyltransferase
DT-diaphorase
Ornithine decarboxylase
a-Aminolevulinic acid synthetase
Glutathione-S-transferase B
'r-Aldehyde dehydrogenase
Choline kinase
varies by sex in the Sprague-Dawley rat, with the fe-
male (25 j,g/kg) being more susceptible than the male
(60 ,ug/kg) (21). The LDI, also varies with age in the
rat, with the weanling male (25 jig/kg) being more sus-
ceptible than the adult male (60 jig/kg) (21). There is a
variation in LD,0 by strain in mice with the C57BL/6J
mouse (132 ,ug/kg) being more susceptible than the DBA/
2J (620 jig/kg) (22). As noted in Table 1, the LD50 for
rabbits also varies by route of administration (23).
Of the various biological effects of the chlorinated
dibenzo-p-dioxins and dibenzofurans, the mechanism of
induction ofthe activity ofenzymes is best understood.
Listed in Table 2 are some of these enzymes whose
activities are temporarily increased in animals exposed
to TCDD and certain other chlorinated dibenzo-p-diox-
ins, dibenzofurans and PCB isomers (17). The increase
in the activity of at least some of these enzymes seen
on administration of TCDD and certain related com-
pounds to experimental animals or incubation ofTCDD
with certain cells in culture, apparently results from a
binding of TCDD to a receptor protein in the cell, and
the translocation of this TCDD-receptor complex into
the nucleus (17). In the nucleus this TCDD-receptor
complex apparently binds to a regulatory gene which
controls the concentration of most if not all of these
enzymes in the cell. This regulatory gene is often re-
ferred to as the Ah locus after Nebert (24). Although a
numberofworkers have contributed to ourunderstand-
ing ofthis process, the original observations have come
from the laboratory of Alan Poland and his colleagues
(25).
Polandhascarried outanumberofstudiescorrelating
the binding of various chlorinated dibenzo-p-dioxins to
thisreceptorproteinwiththebiologicalactivityofthese
same compounds (26). One such studywas acomparison
of the relative affinity of TCDD and other chlorinated
dibenzo-p-dioxins of TCDD for the receptor protein in
the liver cytosol of C57 black 6 mouse with the ability
of these compounds to induce the activity ofthe P-450
enzyme, AHH, in chick embryos. These experiments
showed a good correlation between affinity ofthe com-
pounds forthe receptorand theirabilitytoinduce AHH
in the chick liver.
This study also demonstrated that only those chlor-
inated dibenzo-p-dioxins in which at least three of the
fourlateralpositions (2,3,7or8) onthe dibenzo-p-dioxin
ring system are occupied with chlorine atoms have an
appreciable ability to both bind to the receptor and to
induce AHH in chick embryos at the concentrations
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used in these studies. The acute lethality ofthese chlor-
inated dibenzo-p-dioxin isomers in a specific species of
experimental animal (18) generally follows the same
structure-activity relationship shown in this study for
receptor binding and induction of chick embryo AHH
(17). Additional work in a number oflaboratories using
different strains of mice in which there are variable
levels ofthe receptor, as detected by incubation ofliver
cytosol with 3H-TCDD, have found that the level ofthe
receptor or the affinity of the receptor for TCDD also
correlates with the ability of TCDD to induce the ac-
tivity ofAHH (17) to cause acute toxicity (27), to bring
about thymic involution (28), to produce cleftpalate (28)
or induce hepatic porphyria (29). However, this corre-
lation between the level of the receptor and biological
effects seen in the mouse strains does not hold when
various species are compared.
A comparison ofthe concentrations ofthe TCDD re-
ceptorinthe rat and various strains ofmicehas recently
been published (30) (Table 3). With the exception ofthe
concentrations ofthe receptors in the livers ofthe DBA
mouse and the cross between the C57BL/6J and the
DBA mice, the B6D2F1/J mouse, there are little or no
differences between the mouse strains examined and
the Sprague-Dawley rat.
This comparison has been recently expanded (31). This
more recent study has shown that the level of the re-
ceptor in the liver ofthe guinea pig is not significantly
different than that in the Sprague-Dawley rat, the cy-
nomolgus (Macacafascicularis) monkey, the C57BL/6J
mouse or the Syrian golden hamster. In addition, the
affinity of TCDD for the receptor in these species did
not appear to be significantly different. TCDD does not
increase the activity oftheAhlocus enzymes, AHH and
DT-diaphorase inthe guineapig (32), the most sensitive
species to the acute toxicity ofTCDD. Thus, in contrast
to the data in various mouse strains, there does not
appear to be a correlation between enzyme induction
and the presence of the TCDD-receptor in the guinea
pig. Also, although the concentrations of receptors in
the liver and the affinity of TCDD for these receptors
are very similar in the various species, the acute tox-
icities are quite different. Recall, for example, that the
LD,, ofTCDD in the guinea pig is 2 jig/kg whereas in
the hamster it is >3000 ,ug/kg (Table 1). A possible
reason for the reduced acute lethality of TCDD in the
Table 3. Concentration (n) and dissociation constants (KD) of
the TCDD receptor in rat and mouse hepatic cytosol.a
n, fmole/mg
Species protein KD, nM
Sprague-Dawley rat (7) 61 ± 5 0.12 ± 0.03
C57BL/6J mice
May-July (4) 74 ± 10 0.29 ± 0.01
February-April (3) 47 ± 8 0.29 ± 0.03
DBA/2J mice (3) ND ND
B6D2F1/J mice
February-April (3) 23 ± 2 0.42 ± 0.03
'Data of Gasiewicz and Neal (30).
hamster or its inability to induce the enzymes oftheAh
locus in guinea pigs may be that the TCDD-receptor
complex may not be transferred from the cytosol to the
nucleus in these two species. However, data from the
laboratory of Gasiewicz (personal communication) in-
dicate that under the same in vivo conditions, TCDD is
translocated into the nucleus ofthe rat, mouse, hamster
and the guinea pig in similar amounts. Thus, there are
inconsistencies across species in the concept that the
affinity of TCDD and, perhaps, other chlorinated di-
benzo-p-dioxins and dibenzofurans for the cytosol re-
ceptor as well as the concentration of the receptor is
related to the ability ofthese compounds to induce var-
ious enzymes and to cause other toxic effects including
liver damage and acute lethality. In spite of these in-
consistencies, the data using various mouse strains
(17,27-29) and the results of structure activity studies
(26) suggest thatthe binding ofTCDD and related com-
pounds to the receptor is in some way related to some
of the biological effects of TCDD seen in experimental
animals. Thereisnoreasontobelievethatthe alteration
inthe activity ofenzymes noted inTable2isresponsible
for the toxic effects which are seen. A number of com-
pounds can induce the activity of these same enzymes
but not show the toxic effects seen on exposure to, for
example, TCDD. One possible explanation, among oth-
ers, for these data is that in addition to the binding to
the receptor, TCDD causes additional biological effects
which are necessary for TCDD to interfere with the
normal functioning of the cell, effects for which there
are individual species sensitivities. Studies with mam-
malian cells in culture (33-36) have shown that TCDD
apparently has little or no effect on mammalian cell
division or viability. These data also suggest that the
toxicity of TCDD in whole animals may be related to
the alteration oftwo ormore biological parameters, one
ofwhich may be external to the cells being affected.
Thymic involution is a consistent effect of TCDD in
all animals so far examined. Shown in Table 4 are es-
timations of the concentrations of TCDD required to
reduce the thymus weight by 50% in various species
(31). Note that the doses required to produce thymic
atrophy in the guinea pig are much less than the other
species examined. However, the levels of the receptor
in the thymus does not correlate with these ED values
(31). Thus, the levels of receptor are higher in the rat
thymus than in the guinea pig. Yet a lower dose of
TCDD is required to cause thymic involution in the
guinea pig. A further comparison of receptor concen-
trations in various tissues of the guinea pig, the most
Table 4. Ability of TCDD to produce thymic atrophy in
different species.'
Species ED50, ,ug/kg
Guinea pig 0.5-1.0
Rat 15
Mouse (C57BL/6J) 60
Hamster >300
aData of Gasiewicz (personal communication).
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sensitive species to acute toxicity, and the hamster, the
most resistant, shows that with the exception of the
heart and testes, the concentrations are quite similar
(31).
Another question ofinterest is whether TCDD is me-
tabolized and, if so, what is the effect ofmetabolism on
the acute toxicity ofTCDD. In other words, what com-
poundisresponsible for acutetoxicity-the parent com-
pound or a metabolite or metabolites?
Until recently, there was some question whether
TCDD was metabolized in animals, particularly since it
appears to be a poor substrate for soil bacteria. How-
ever, the work of Rose et al. (37), Poiger and Schlatter
(38) and Olson et al. (39) have provided convincing evi-
dence that TCDD is slowly metabolized in a number of
species.
When 500 ,ug/kg 3H-TCDD is administered to ham-
sters and the urine collected for 24 hr starting on day
7 following administration of TCDD, no parent com-
pound was found in the urine during this period (39).
However, a number of compounds more polar than
TCDD were found in the urine, some of which are ap-
parently present as glucuronides (40). Also, some ofthe
metabolites observed were likely ethereal sulfate de-
rivatives ofTCDD. An examination ofthe bile collected
from these same animals again reveals no parent com-
pound but a number of metabolites of TCDD, some of
which appear to be glucuronide derivatives.
Incubation of 3H-TCDD with primary hepatocytes
isolated from hamsters and rats leads to the accumu-
lation of a number of metabolites of TCDD in the in-
Table 5. Tbxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
to male weanling rats pretreated with phenobarbital (Pb),
3-methylcholanthrene (3-MC), or TCDD.a
Treatment LD50, jig/kg, mean ± SE
None 25.2 ± 1.4
Pb 40.9 ± 1.3b
3-MC 44.1 ±1.2b
TCDD 36.8 ± 1.8b
a Data of Beatty et al. (21).
b Significantly (p < 0.05) different from controls (none).
cubation media, some ofwhich appear to be glucuronides
(40,41). Additional data indicate the presence of ethe-
real sulfate derivatives ofTCDD. Similar results to these
have also been obtained usinghepatocytes isolated from
rats, hamsters and mice (40).
The major metabolites formed on incubation of pri-
mary rat hepatocytes with TCDD are 1-hydroxy-2,3,7,8-
tetrachlorodibenzo-p-dioxin and 8-hydroxy-2,3, 7-trich-
lorodibenzo-p-dioxin (41). These two metabolites rep-
resented about 60% of the metabolic products present
in the incubation.
It is logical that the enzyme responsible for the for-
mation of the metabolites of TCDD seen on incubation
with primary rat hepatocytes is the cytochrome P-450
monooxygenase system. In order to verify this, the ef-
fect of pretreatment of rats with the cytochrome P-450
inducer, phenobarbital (Pb) on the ability of the hepa-
tocytes to metabolize TCDD was examined (40). It was
found that pretreatment ofrats with Pb leads to marked
increase in the rate ofmetabolism ofTCDD by primary
hepatocytes as compared to controls. Also, pretreat-
mentwith asmall dose (5 ,ug/kg) ofTCDD alsomarkedly
increased the rate of metabolism of TCDD by primary
rat hepatocytes. When rat hepatocytes were incubated
with TCDD in the presence of SKF 525-A (0.1 mM) or
metyrapone (0.5 mM), the metabolism of TCDD to the
phenolic derivatives.
In order to assess whether the parent compound or
metabolites were responsible for the acute toxicity, the
LD50 of TCDD in weanling rats and in weanling rats
pretreated with Pb (50 mg/kg/3 days), 3-methylchol-
anthrene (3-MC) (40 mg/kg), and TCDD (5 ,ug/kg) was
determined (Table 5) (21). In the rats pretreated with
Pb, 3-MC and TCDD, the LD50 was increased relative
to controls. These data suggest that metabolism leads
to a decrease in the acute toxicity. This is reinforced by
data from the work of Poiger and Buser (42) who ad-
ministered the metabolites of3H-TCDD excreted in the
bile of a dog to guinea pigs. On a molar basis (based on
radioactivity), the metabolites in the bile were >100
times less toxic than TCDD itself.
Table 6. Rates of elimination, AHH induction and toxicity of TCDD in various species.a
Half-life for
Species Dose, pg/kg elimination tl,2, days AHH induction LD50, pg/kg Reference
Guinea pig 2.0 30 No 2 (43)
(IP)
Rat 1.0 31 Yes 60 (37)
(Oral)
Mouse
C57BL/6J 10.0 17 Yes 132 (22)
(IP)
DBA/2J 10.0 37 Yes 620 (22)
(IP)
B6D2F1/J 10.0 17 Yes 300 (22)
(IP)
Hamster 650 11 Yes > 3000 (19)
(IP)
Hamster 650 15 Yes 5051 (19,20)
(Oral)
aData of Gasiewicz et al. (43).
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Shown in Table 6 are the half-lives of elimination of
TCDD in various species compared with the LD50 of
TCDD in those same species (43). Note that the half-
life for elimination of TCDD in the guinea pig and rat
are the same, yet the LD5, values are quite different.
Note also that in the various mouse strains, the strain
with the longest half-life ofelimination, the DBA, is the
least sensitive to the acute lethal effects. Also, in the
hamster, which is quite resistant to the acute lethal
effects of TCDD, the half-life of elimination of TCDD
is not greatly different than, for example, the C57/B6
mouse. These data indicate the acute lethality ofTCDD
is apparently not directly related to the residence time
ofTCDD in the organism. And, since residence time is
apparently related, at least in part, to the rate of me-
tabolism ofTCDD, the acute toxic effects are probably
not directly related to the rate of metabolism of the
compound.
REFERENCES
1. Olie, K., Vermeulen, P. L., and Hutzinger, 0. Chlorodibenzo-p-
dioxins and chlorodibenzofurans are trace components of flyash
and flue gas of some municipal incinerators in the Netherlands.
Chemosphere 6: 455-459 (1978).
2. Buser, H. R., and Bosshardt, H. P. Polychlorierte Dibenzo-p-
dioxine, Dibenzofurane und Benzole in der Asche Kommunaler
und industrieller Verbrennungsanlagen. Mitt. Geb. Lebensmitt.
Hyg. 69: 191-199 (1978).
3. Goldstein, J. A., Hickman, P., Bergman, H., McKinney, J. D.,
and Walker, M. P. Separation of pure polychlorinated biphenyl
isomers into two types of inducers on the basis of induction of
cytochrome P-450 orP-448. Chem.-Biol. Interact. 17: 69-87 (1977).
4. Barsotti, D. A., Marlar, R. J., and Allen, J. R. Reproductive
dysfunction in rhesus monkeys exposed to low levels ofpolychlo-
rinated biphenyls. Food Cosmet. Toxicol. 14: 99-103 (1976).
5. Vos, J. G., and Beems, R. B. Dermal toxicity studies oftechnical
polychlorinated biphenyls and fractions thereof in rabbits. Toxi-
col. Appl. Pharmacol. 19: 617-633 (1971).
6. Lambrecht, L. K., Barsotti, D. A., and Allen, J. R. Responses
of nonhuman primates to a polybrominated biphenyl mixture.
Environ. Health Perspect. 23: 139-145 (1978).
7. Strik, J. J. T. W. A. Porphyrinogenic action ofpolyhalogenated
aromatic compounds with special reference to porphyria and en-
vironmental impact. In: Proceedings International Symposium on
Clinical Biochemistry, Diagnosis and Therapy ofPorphyrias and
Lead Intoxication (M. Doss, Ed.), Springer-Verlag, Berlin, 1978,
pp. 151-164.
8. Vos, J. G., and de Roij, T. Immunosuppressive activity of a pol-
ychlorinated biphenyl preparation on the humoral immune re-
sponse in guinea pigs. Toxicol. Appl. Pharmacol. 21: 549-555
(1972).
9. McConnell, E. E., Hass, J. R., Altman, N., and Moore, J. A. A
spontaneous outbreak ofpolychlorinated biphenyl (PCB) toxicity
in rhesus monkeys (Macaca mulatta): toxicopathology. Lab. Anim.
Sci. 29: 666-673 (1979).
10. Kimbrough, R. D., Squire, R. A., Linder, R. E., Strandberg, J.
D., Montali, R. J., and Burse, V. W. Induction of liver tumors
inShermanstrainfemaleratsbypolychlorinated biphenylAroclor
1260. J. Natl. Cancer Inst. 55: 1453-1459 (1975).
11. Poland, A., and Glover, E. Chlorinated biphenyl induction ofaryl
hydrocarbon hydroxylase activity: a study ofthe structure-activ-
ity relationship. Mol. Pharmacol. 13: 924-938 (1977).
12. Preston, B. D., Van Miller, J. P., Moore, R. W., and Allen, J.
A. Promoting effects ofpolychlorinated biphenyls (Aroclor 1254)
and polychlorinated dibenzofuran-free Aroclor 1254 on diethyl-
nitrosamine-induced tumorigenesis in the rat. J. Natl. Cancer
Inst. 66: 509-515 (1981).
13. Oesterle, D., and Deml, E. Promoting effect of polychlorinated
biphenyls on development of enzyme-altered islands in livers of
weanling and adult rats. J. Cancer Res. Clin. Oncol. 105: 141-
147 (1983).
14. Kimura, N. T., Kanematsu, T., and Baba, T. Polychlorinated
biphenyl(s) as a promotor in experimental hepatocarcinogenesis
in rats. Z. Krebsforsch. Klin. Onkol. 87: 257-266 (1976).
15. Elder, G. H. Porphyria caused by hexachlorobenzene and other
polyhalogenated aromatic hydrocarbons. In: Heme and hemopro-
teins (F. De Matteis andW. N. Aldridge, Eds.), Springer-Verlag,
Berlin, 1978, pp. 157-200.
16. Elder, G. H., and Sheppard, D. M. Immunoreactive uropor-
phyrinogen decarboxylase is unchanged in porphyria caused by
TCDD and hexachlorobenzene. Biochem. Biophys. Res. Com-
mun. 109: 113-120 (1982).
17. Poland, A., and Knutson, J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin
and related halogenated aromatic hydrocarbons: examination of
themechanismoftoxicity. Ann. Rev. Pharmacol. Toxicol. 22: 517-
554 (1982).
18. McConnell, E. E., Moore, J. A., Haseman, J. K., and Harris, M.
W. The comparative toxicity of chlorinated dibenzo-p-dioxins in
miceandguineapigs. Toxicol. Appl. Pharmacol. 44: 335-356 (1978).
19. Olson, J. R., Holscher, M. A., and Neal, R. A. Toxicity of2,3,7,8-
tetrachlorodibenzo-p-dioxin in the golden Syrian hamster. Toxi-
col. Appl. Pharmacol. 55: 67-78 (1980).
20. Henck, J. M., New, M. A., Kociba, R. J., and Rao, K. S. 2,3,7,8-
Tetrachlorodibenzo-p-dioxin: acute oral toxicity inhamsters. Tox-
icol. Appl. Pharmacol. 59: 405-407 (1981).
21. Beatty, P. W., Vaughn, W. K., and Neal, R. A. Effect of alter-
ation ofrat hepatic mixed-function oxidase (MFO) activity on the
toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol.
Appl. Pharmacol. 45: 513-519 (1978).
22. Gasiewicz, T. A., Geiger, L. E., Rucci, G., and Neal, R. A.
Distribution, excretion, and metabolism of 2,3,7,8-tetrachloro-
dibenzo-p-dioxin in C57BL/6J, DBA/2J, and B6D2F1/J mice. Drug
Metab. Dispos. 11: 397-403 (1983).
23. Schwetz, B. A., Norris, J. M., Sparschu, G. L., Rowe, V. K.,
Gehring, P. J., Emerson, J. L., and Gerbig, C. G. Toxicology of
chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 5: 87-
99 (1973).
24. Nebert, D. W., and Gielen, J. E. Genetic regulation of aryl hy-
drocarbon hydroxylase induction in the mouse. Fed. Proc. 31:
1315-1327 (1972).
25. Poland, A. Glover, E., and Kende, A. S. Stereospecific, high
affinity binding of2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic
cytosol. J. Biol. Chem. 251: 4936-4946 (1976).
26. Poland, A., Greenlee, W. E., and Kende, A. S. Studies on the
mechanism of action of ten chlorinated dibenzo-p-dioxins and re-
lated compounds. Ann. N.Y. Acad. Sci. 320: 214-230 (1979).
27. Neal, R. A., Olson, J. R., Gasiewicz, T. A., and Geiger, L. E.
The toxicokinetics of2,3,7,8-tetrachlorodibenzo-p-dioxin in mam-
malian systems. Drug Metab. Rev. 13: 355-385 (1982).
28. Poland, A., and Glover, E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin:
studies on the mechanism of action. In: The Scientific Bases of
Toxicity Assessment (H. Witschi, Ed.), Elsevier/North Holland
Biomedical Press, New York, 1980, pp. 223-239.
29. Jones, K. G., and Sweeney, G. P. Dependence of the porphyro-
genic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin upon inherit-
ance of aryl hydrocarbon hydroxylase responsiveness. Toxicol.
Appl. Pharmacol. 53: 42-49 (1980).
30. Gasiewicz, T. A., and Neal, R. A. The examination and quanti-
tation oftissue cytosolic receptors for2,3,7,8-tetrachlorodibenzo-
p-dioxin using hydroxylapatite. Anal. Biochem. 124: 1-11 (1982).
31. Gasiewicz, T. A. Receptors for2,3,7,8-tetrachlorodibenzo-p-dioxin:
their inter-and intra-species distribution and relationship to the
toxicity ofthiscompound. In: Proceedings, Thirteenth Conference
on Environ. Toxicology, November 16-18, 1982. Air Force Aer-
ospace Medical Research Laboratory, Wright-Patterson Air Force
Base, OH, (AFAMRL-TR-82-101) August 1983, pp. 250-269.
32. Neal, R. A., Beatty, P. W., and Gasiewicz, T. A. Studies of the
mechanisms of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). Ann. N.Y. Acad. Sci. 320: 204-213 (1979).46 R. A. NEAL
33. Beatty, P. W., Lemack, K. J., Holscher, M. A., and Neal, R. A.
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on mam-
malian cells in tissue culture. Toxicol. Appl. Pharmacol. 31: 309-
312 (1975).
34. Kouri, R. E., Ratrie, H., Atlas, S. A., Niwa, A., and Nebert,
D. W. Aryl hydrocarbon hydroxylase induction in human lym-
phocyte cultures by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Life Sci.
15: 1585-1595 (1974).
35. Knutson, J. C., and Poland, A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin:
failure to demonstrate toxicity in twenty-three cultured cell types.
Toxicol. Appl. Pharmacol. 54: 377-383 (1980).
36. Niwa, A., Kumaki, K., and Nebert, D. W. Induction of aryl
hydrocarbon hydroxylase activity in various cell cultures by2,3,7,8-
tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 11: 399-408 (1975).
37. Rose, J. Q., Ramsey, J. C., Mentzler, T. A., Hummel, R. A.,
and Gehring, P. J. The fate of2,3,7,8-tetrachlorodibenzo-p-dioxin
following single and repeated oral doses to the rat. Toxicol. Appl.
Pharmacol. 36: 209-226 (1976).
38. Poiger, H., and Schlatter, C. Biological degradation ofTCDD in
rats. Nature 281: 706-707 (1979).
39. Olson, J. R., Gasiewicz, T. A., and Neal, R. A. Tissue distri-
bution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) in the golden Syrian hamster. Toxicol. Appl.
Pharmacol. 56: 78-85 (1980).
40. Olson, J. R., Gasiewicz, T. A., Geiger, L. E., and Neal, R. A.
The metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mam-
malian systems. In: Accidental Exposure to Dioxins (F. Coulston
and F. Pocchiari, Eds.), Academic Press, New York, 1983, pp.
81-103.
41. Sawahata, T., Olson, J. R., and Neal, R. A. Identification of
metabolites of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) formed
on incubation with isolated rat hepatocytes. Biochem. Biophys.
Res. Commun. 105: 341-346 (1982).
42. Poiger, H., and Buser, H. R. Structure elucidation ofmammalian
TCDD-metabolites. In: Human and Environmental Risks of
Chlorinated Dioxins and Related Compounds (R. Tucker, A. Young
and A. Gray, Eds.), Plenum Press, New York, 1983, pp. 483-
492.
43. Gasiewicz, T. A., Olson, J. R., Geiger, L. H., and Neal, R. A.
Absorption, distribution and metabolism of 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD)inexperimentalanimals. In: Humanand
Environmental Risks of Chlorinated Dioxins and Related Com-
pounds (R. Tucker, A. Young and A. Gray, Eds.), Plenum Press,
New York, 1983, pp. 495-525.